Your browser doesn't support javascript.
loading
Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer.
Fu, Shengya; Li, Linjuan; Li, Xiaofen; Wu, Qiang; Wang, Xiaohui; Huang, Yan; Hu, Haoyue; Cao, Dan.
Afiliación
  • Fu S; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, SC, China.
  • Li L; Second Department of Oncology, Sichuan Friendship Hospital, Chengdu, SC, China.
  • Li X; Department of Abdominal Oncology, West China Hospital, Sichuan University/ West China School of Nursing, Sichuan University, Chengdu, SC, China.
  • Wu Q; Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, SC, China.
  • Wang X; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, SC, China.
  • Huang Y; Second Department of Oncology, Sichuan Friendship Hospital, Chengdu, SC, China.
  • Hu H; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, SC, China.
  • Cao D; Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Medicine School of University of Electronic Science and Technology, Chengdu, SC, China.
Front Pharmacol ; 13: 888106, 2022.
Article en En | MEDLINE | ID: mdl-36034835
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article